Literature DB >> 27366833

Policy Framework for Covering Preventive Services Without Cost Sharing: Saving Lives and Saving Money?

Stephanie C Chen1, Steven D Pearson2.   

Abstract

The US Affordable Care Act mandates that private insurers cover a list of preventive services without cost sharing. The list is determined by 4 expert committees that evaluate the overall health effect of preventive services. We analyzed the process by which the expert committees develop their recommendations. Each committee uses different criteria to evaluate preventive services and none of the committees consider cost systematically. We propose that the existing committees adopt consistent evidence review methodologies and expand the scope of preventive services reviewed and that a separate advisory committee be established to integrate economic considerations into the final selection of free preventive services. The comprehensive framework and associated criteria are intended to help policy makers in the future develop a more evidence-based, consistent, and ethically sound approach.

Mesh:

Year:  2016        PMID: 27366833     DOI: 10.1001/jamainternmed.2016.3052

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  2 in total

1.  Trends in receipt of sexually transmitted disease services among women 15 to 44 years old in the United States, 2002 to 2006-2010.

Authors:  Laura T Haderxhanaj; Thomas L Gift; Penny S Loosier; Ryan C Cramer; Jami S Leichliter
Journal:  Sex Transm Dis       Date:  2014-01       Impact factor: 2.830

2.  Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.

Authors:  Samir Gupta; Ethan A Halm; Don C Rockey; Marcia Hammons; Mark Koch; Elizabeth Carter; Luisa Valdez; Liyue Tong; Chul Ahn; Michael Kashner; Keith Argenbright; Jasmin Tiro; Zhuo Geng; Sandi Pruitt; Celette Sugg Skinner
Journal:  JAMA Intern Med       Date:  2013-10-14       Impact factor: 21.873

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.